With the recent advancement of molecular techniques to diagnose thyroid neoplasm, amounting evidence has proved that BRAFV600E -based FNA distinctly increases the detection rate of BRAF-mutated associated thyroid neoplasm.[5,6] However, studies on multi-gene testing have been mainly limited to the western population[7–10] and are less common in Asians. Here, BRAF is linked to thyroid tumor.